Strengthening peaceful coexistence and
healing broken hearts
“For Christ’s love compels us, because we are convinced that one died for all, and therefore all died” (2Cor 5:14)
OUR VISION
TEKAN Peace Desk is committed to the pursuit of justice, peace and religious tolerance and improved livelihood
OUR MISSION
“We exist to promote justice, peace, religious tolerance and improved livelihood in collaboration with churches and communities through capacity development and humanitarian response”.
OUR CORE VALUES
- Justice and Peace - Being Christ-like.
- Commitment, Hard Work and Team Spirit - Being passionate for service delivery
- Capacity Development- Training and retaining of staff and communities.
about us
TEKAN Peace Desk is a faith-based, non- profit, non-governmental organization working in the area of peace building, conflict transformation and psychosocial support with focus on Northern Nigeria in particular and Nigeria at large with a vision of stakeholders becoming advocates of peace which enhances sustainable growth and development of communities and the nation.
TEKAN Peace Desk is the project arm of TEKAN also known as Fellowship of Churches of Christ in Nigeria in English. TEKAN is a federation of Christian denominations in Nigeria founded in 1955

Building Bridges
Building bridges is TEKAN Peace Desks number one flagship radio advocacy program. It is anchored on Upright Morality, Religious Tolerance, Peace, Justice and a vibrant economy
- Messages of Peace
- Conflict Resolution
- Society Building

Village Square Podcast
Village Square Podcasts is designed to create awareness to people in parts of the society on peace and unity. It encourages and fosters inter communal ties
- Inter-communal Relationship
- Business Support
- Peace Meeetings
PODCASTS/RADIO PROGRAMMS

Building Bridges
Building Bridges is TEKAN Peace Desk's number one flagship radio advocacy program. It is anchored on Upright Morality, Religious Tolerance, Peace, Justice and a vibrant economy
- Messages of Peace
- Conflict Resolution
- Society Building
- Peace Advocacy

Village Square Podcast
Local issues with global perspectives
- Inter-communal Relationship
- Business Support
- Peace Meeetings
- Socio-Cultural Development
PROJECTS/THEMATIC AREAS
Peace Building & Conflict Transformation
For more than a decade, insurgency, ethno-religious, intra/inter church and political differences has ravaged many communities in northern Nigeria. Records show that over 3.2 million people are displaced including 2.9 million in the Northeast alone, making it the third highest number of IDPs in Africa..........
Trauma Healing and Psychosocial Support
Increased armed violence, intercommunal and ethnos religious crisis, banditry, and kidnapping in Northern Nigeria have adversely affected the region with increased displacement of people fleeing their homes for safety. The American project report of 2021 noted that about 200,000 people have fled their communities in Northern Nigeria with 77,000 of them leaving the country for a safer place.....
Humanitarian Response;
Increased insecurity in Northern Nigeria has exacerbated the humanitarian situation of the region. The number of internally displaced persons within TEKAN intervention area (North East 1, 560,537 IDPs, North Central, South East, and North West) as a result of insurgency, banditry, kidnapping, ethno-religious conflicts and natural disasters has ascended overtime. This has resulted to deaths, loss of livelihoods also resulting in increased poverty levels......
Governance & Advocacy;
TEKAN has a fellowship of 15 member churches with over 25 million members across Northern Nigeria and beyond. TEKAN Peace Desk is saddled with the responsibility of equipping congregants and community members with relevant advocacy tools and strategies to advocate and demand for governance. This is with a view to strengthening delivery of good governance to rural communities and less developed areas to improve their standard of living. The Desk carries out several capacity building training sessions for selected church and community across Northern Nigeria...
Food Security & Livelihoods
Food insecurity and high level of unemployment in TEKAN intervention areas (North East 1,560,537 IDPs, North Central, South East, North West) due to insecurity, natural disasters, climate change, harsh economic environment, skills deficit, high inflation resulting to increased rate of crime, hunger, youth restiveness, increase level of poverty and drug abuse. TEKAN Peace Desk works to empower vulnerable households to achieve food security and reduce unemployment across project communities.
Media Engagement/Advocacy:
We currently run two radio programmes aimed towards…
SPONSORS





Coronavirus disease 2019
COVID-19 is a contagious disease caused by the coronavirus SARS-CoV-2. In January 2020, the disease spread worldwide, resulting in the COVID-19 pandemic. The symptoms of COVID‑19 can vary but often include fever,[7] fatigue, cough, breathing difficulties, loss of smell, and loss of taste.[8][9][10] Symptoms may begin one to fourteen days after exposure to the virus. At least a third of people who are infected do not develop noticeable symptoms.[11][12] Of those who develop symptoms noticeable enough to be classified as patients, most (81%) develop mild to moderate symptoms (up to mild pneumonia), while 14% develop severe symptoms (dyspnea, hypoxia, or more than 50% lung involvement on imaging), and 5% develop critical symptoms (respiratory failure, shock, or multiorgan dysfunction).[13] Older people have a higher risk of developing severe symptoms. Some complications result in death. Some people continue to experience a range of effects (long COVID) for months or years after infection, and damage to organs has been observed.[14] Multi-year studies on the long-term effects are ongoing.[15] COVID‑19 transmission occurs when infectious particles are breathed in or come into contact with the eyes, nose, or mouth. The risk is highest when people are in close proximity, but small airborne particles containing the virus can remain suspended in the air and travel over longer distances, particularly indoors. Transmission can also occur when people touch their eyes, nose, or mouth after touching surfaces or objects that have been contaminated by the virus. People remain contagious for up to 20 days and can spread the virus even if they do not develop symptoms.[16] Testing methods for COVID-19 to detect the virus’s nucleic acid include real-time reverse transcription polymerase chain reaction (RT‑PCR),[17][18] transcription-mediated amplification,[17][18][19] and reverse transcription loop-mediated isothermal amplification (RT‑LAMP)[17][18] from a nasopharyngeal swab.[20] Several COVID-19 vaccines have been approved and distributed in various countries, many of which have initiated mass vaccination campaigns. Other preventive measures include physical or social distancing, quarantining, ventilation of indoor spaces, use of face masks or coverings in public, covering coughs and sneezes, hand washing, and keeping unwashed hands away from the face. While drugs have been developed to inhibit the virus, the primary treatment is still symptomatic, managing the disease through supportive care, isolation, and experimental measures.
Coronavirus disease 2019
COVID-19 is a contagious disease caused by the coronavirus SARS-CoV-2. In January 2020, the disease spread worldwide, resulting in the COVID-19 pandemic. The symptoms of COVID‑19 can vary but often include fever,[7] fatigue, cough, breathing difficulties, loss of smell, and loss of taste.[8][9][10] Symptoms may begin one to fourteen days after exposure to the virus. At least a third of people who are infected do not develop noticeable symptoms.[11][12] Of those who develop symptoms noticeable enough to be classified as patients, most (81%) develop mild to moderate symptoms (up to mild pneumonia), while 14% develop severe symptoms (dyspnea, hypoxia, or more than 50% lung involvement on imaging), and 5% develop critical symptoms (respiratory failure, shock, or multiorgan dysfunction).[13] Older people have a higher risk of developing severe symptoms. Some complications result in death. Some people continue to experience a range of effects (long COVID) for months or years after infection, and damage to organs has been observed.[14] Multi-year studies on the long-term effects are ongoing.[15] COVID‑19 transmission occurs when infectious particles are breathed in or come into contact with the eyes, nose, or mouth. The risk is highest when people are in close proximity, but small airborne particles containing the virus can remain suspended in the air and travel over longer distances, particularly indoors. Transmission can also occur when people touch their eyes, nose, or mouth after touching surfaces or objects that have been contaminated by the virus. People remain contagious for up to 20 days and can spread the virus even if they do not develop symptoms.[16] Testing methods for COVID-19 to detect the virus’s nucleic acid include real-time reverse transcription polymerase chain reaction (RT‑PCR),[17][18] transcription-mediated amplification,[17][18][19] and reverse transcription loop-mediated isothermal amplification (RT‑LAMP)[17][18] from a nasopharyngeal swab.[20] Several COVID-19 vaccines have been approved and distributed in various countries, many of which have initiated mass vaccination campaigns. Other preventive measures include physical or social distancing, quarantining, ventilation of indoor spaces, use of face masks or coverings in public, covering coughs and sneezes, hand washing, and keeping unwashed hands away from the face. While drugs have been developed to inhibit the virus, the primary treatment is still symptomatic, managing the disease through supportive care, isolation, and experimental measures.
Verwen jezelf met de onweerstaanbare slap kong promo code
Auto-generated post_excerpt
Revolucija stavljenja z Rainbet aplikacijo za nepozabne zmage
Auto-generated post_excerpt
Coronavirus disease 2019
COVID-19 is a contagious disease caused by the coronavirus SARS-CoV-2. In January 2020, the disease spread worldwide, resulting in the COVID-19 pandemic. The symptoms of COVID‑19 can vary but often include fever,[7] fatigue, cough, breathing difficulties, loss of smell, and loss of taste.[8][9][10] Symptoms may begin one to fourteen days after exposure to the virus. At least a third of people who are infected do not develop noticeable symptoms.[11][12] Of those who develop symptoms noticeable enough to be classified as patients, most (81%) develop mild to moderate symptoms (up to mild pneumonia), while 14% develop severe symptoms (dyspnea, hypoxia, or more than 50% lung involvement on imaging), and 5% develop critical symptoms (respiratory failure, shock, or multiorgan dysfunction).[13] Older people have a higher risk of developing severe symptoms. Some complications result in death. Some people continue to experience a range of effects (long COVID) for months or years after infection, and damage to organs has been observed.[14] Multi-year studies on the long-term effects are ongoing.[15] COVID‑19 transmission occurs when infectious particles are breathed in or come into contact with the eyes, nose, or mouth. The risk is highest when people are in close proximity, but small airborne particles containing the virus can remain suspended in the air and travel over longer distances, particularly indoors. Transmission can also occur when people touch their eyes, nose, or mouth after touching surfaces or objects that have been contaminated by the virus. People remain contagious for up to 20 days and can spread the virus even if they do not develop symptoms.[16] Testing methods for COVID-19 to detect the virus’s nucleic acid include real-time reverse transcription polymerase chain reaction (RT‑PCR),[17][18] transcription-mediated amplification,[17][18][19] and reverse transcription loop-mediated isothermal amplification (RT‑LAMP)[17][18] from a nasopharyngeal swab.[20] Several COVID-19 vaccines have been approved and distributed in various countries, many of which have initiated mass vaccination campaigns. Other preventive measures include physical or social distancing, quarantining, ventilation of indoor spaces, use of face masks or coverings in public, covering coughs and sneezes, hand washing, and keeping unwashed hands away from the face. While drugs have been developed to inhibit the virus, the primary treatment is still symptomatic, managing the disease through supportive care, isolation, and experimental measures.
Coronavirus disease 2019
COVID-19 is a contagious disease caused by the coronavirus SARS-CoV-2. In January 2020, the disease spread worldwide, resulting in the COVID-19 pandemic. The symptoms of COVID‑19 can vary but often include fever,[7] fatigue, cough, breathing difficulties, loss of smell, and loss of taste.[8][9][10] Symptoms may begin one to fourteen days after exposure to the virus. At least a third of people who are infected do not develop noticeable symptoms.[11][12] Of those who develop symptoms noticeable enough to be classified as patients, most (81%) develop mild to moderate symptoms (up to mild pneumonia), while 14% develop severe symptoms (dyspnea, hypoxia, or more than 50% lung involvement on imaging), and 5% develop critical symptoms (respiratory failure, shock, or multiorgan dysfunction).[13] Older people have a higher risk of developing severe symptoms. Some complications result in death. Some people continue to experience a range of effects (long COVID) for months or years after infection, and damage to organs has been observed.[14] Multi-year studies on the long-term effects are ongoing.[15] COVID‑19 transmission occurs when infectious particles are breathed in or come into contact with the eyes, nose, or mouth. The risk is highest when people are in close proximity, but small airborne particles containing the virus can remain suspended in the air and travel over longer distances, particularly indoors. Transmission can also occur when people touch their eyes, nose, or mouth after touching surfaces or objects that have been contaminated by the virus. People remain contagious for up to 20 days and can spread the virus even if they do not develop symptoms.[16] Testing methods for COVID-19 to detect the virus’s nucleic acid include real-time reverse transcription polymerase chain reaction (RT‑PCR),[17][18] transcription-mediated amplification,[17][18][19] and reverse transcription loop-mediated isothermal amplification (RT‑LAMP)[17][18] from a nasopharyngeal swab.[20] Several COVID-19 vaccines have been approved and distributed in various countries, many of which have initiated mass vaccination campaigns. Other preventive measures include physical or social distancing, quarantining, ventilation of indoor spaces, use of face masks or coverings in public, covering coughs and sneezes, hand washing, and keeping unwashed hands away from the face. While drugs have been developed to inhibit the virus, the primary treatment is still symptomatic, managing the disease through supportive care, isolation, and experimental measures.